Published in
Elsevier, European Neuropsychopharmacology, (80), p. 27-35, 2024
DOI: 10.1016/j.euroneuro.2023.12.006
Links
Tools
Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial
Journal article published in 2024 by
Marcelo Falchi-Carvalho 
,
Isabel Wießner ,
Sérgio Ruschi B. Silva ,
Lucas O． Maia ,
Handersson Barros,
Sophie Laborde,
Flávia Arichelle,
Sam Tullman,
Natan Silva-Costa,
Aline Assunção,
Raissa Almeida ,
Érica J. Pantrigo ,
Raynara Bolcont ,
José Victor Costa-Macedo,
Emerson Arcoverde
and other authors.
,
Isabel Wießner ,
Sérgio Ruschi B. Silva ,
Lucas O． Maia ,
Handersson Barros,
Sophie Laborde,
Flávia Arichelle,
Sam Tullman,
Natan Silva-Costa,
Aline Assunção,
Raissa Almeida ,
Érica J. Pantrigo ,
Raynara Bolcont ,
José Victor Costa-Macedo,
Emerson Arcoverde
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 